178 related articles for article (PubMed ID: 37740742)
21. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
22. Impact of the new ultra-high sensitivity mode in a long axial field-of-view PET/CT.
Mingels C; Weidner S; Sari H; Buesser D; Zeimpekis K; Shi K; Alberts I; Rominger A
Ann Nucl Med; 2023 May; 37(5):310-315. PubMed ID: 36913094
[TBL] [Abstract][Full Text] [Related]
23. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors.
Rominger A; Saam T; Vogl E; Ubleis C; la Fougère C; Förster S; Haug A; Cumming P; Reiser MF; Nikolaou K; Bartenstein P; Hacker M
J Nucl Med; 2010 Feb; 51(2):193-7. PubMed ID: 20080898
[TBL] [Abstract][Full Text] [Related]
24. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Kroiss A; Putzer D; Uprimny C; Decristoforo C; Gabriel M; Santner W; Kranewitter C; Warwitz B; Waitz D; Kendler D; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
[TBL] [Abstract][Full Text] [Related]
25. 68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT.
Kroiss A; Putzer D; Decristoforo C; Uprimny C; Warwitz B; Nilica B; Gabriel M; Kendler D; Waitz D; Widmann G; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):514-23. PubMed ID: 23291643
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of late acquisition [68Ga]Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer-first clinical experiences.
Alberts I; Prenosil G; Mingels C; Bohn KP; Viscione M; Sari H; Rominger A; Afshar-Oromieh A
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4456-4462. PubMed ID: 34155538
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor.
Hope TA; Pampaloni MH; Nakakura E; VanBrocklin H; Slater J; Jivan S; Aparici CM; Yee J; Bergsland E
Abdom Imaging; 2015 Aug; 40(6):1432-40. PubMed ID: 25820755
[TBL] [Abstract][Full Text] [Related]
28. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for
Mohr P; van Sluis J; Providência L; van Snick JH; Lub-de Hooge MN; Willemsen AT; Glaudemans AWJM; Boellaard R; Lammertsma AA; Brouwers AH; Tsoumpas C
J Nucl Med; 2023 Nov; 64(11):1815-1820. PubMed ID: 37536740
[TBL] [Abstract][Full Text] [Related]
29. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
[TBL] [Abstract][Full Text] [Related]
30. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.
Rinne P; Hellberg S; Kiugel M; Virta J; Li XG; Käkelä M; Helariutta K; Luoto P; Liljenbäck H; Hakovirta H; Gardberg M; Airaksinen AJ; Knuuti J; Saraste A; Roivainen A
Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428
[TBL] [Abstract][Full Text] [Related]
32. Preliminary PET/CT Imaging with Somatostatin Analogs [
Satpati D; Shinto A; Kamaleshwaran KK; Sarma HD; Dash A
Mol Imaging Biol; 2017 Dec; 19(6):878-884. PubMed ID: 28349291
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance and impact on patient management of [68Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut.
Delabie P; Baudin É; Hentic O; Afchain P; Rusu T; Montravers F
Medicine (Baltimore); 2022 Nov; 101(47):e31512. PubMed ID: 36451394
[TBL] [Abstract][Full Text] [Related]
34. 64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients.
Malmberg C; Ripa RS; Johnbeck CB; Knigge U; Langer SW; Mortensen J; Oturai P; Loft A; Hag AM; Kjær A
J Nucl Med; 2015 Dec; 56(12):1895-900. PubMed ID: 26429961
[TBL] [Abstract][Full Text] [Related]
35. [Value of
Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
[TBL] [Abstract][Full Text] [Related]
36. Same-day comparative protocol PET/CT-PET/MRI [
Prado-Wohlwend S; Ballesta-Moratalla M; Torres-Espallardo I; Del Olmo-García MI; Bello-Arques P; Olivas-Arroyo C; Merino-Torres JF
Cancer Imaging; 2023 Jan; 23(1):4. PubMed ID: 36627700
[TBL] [Abstract][Full Text] [Related]
37.
Ashwathanarayana AG; Singhal M; Satapathy S; Sood A; Mittal BR; Kumar RM; Parmar M; Krishnappa D; Rana N
J Nucl Cardiol; 2022 Apr; 29(2):558-568. PubMed ID: 32720061
[TBL] [Abstract][Full Text] [Related]
38. Tumour-to-liver ratio determined by [
Kim YI; Yoo C; Oh SJ; Lee SJ; Kang J; Hwang HS; Hong SM; Ryoo BY; Ryu JS
EJNMMI Res; 2020 Jun; 10(1):63. PubMed ID: 32542576
[TBL] [Abstract][Full Text] [Related]
39. Three-Hour Delayed Imaging Improves Assessment of Coronary
Kwiecinski J; Berman DS; Lee SE; Dey D; Cadet S; Lassen ML; Germano G; Jansen MA; Dweck MR; Newby DE; Chang HJ; Yun M; Slomka PJ
J Nucl Med; 2019 Apr; 60(4):530-535. PubMed ID: 30213848
[TBL] [Abstract][Full Text] [Related]
40. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
